{"version":"1.0","provider_name":"CTGCT","provider_url":"https:\/\/ctgct.si\/en\/","author_name":"Rodrigo Ortiz","author_url":"https:\/\/ctgct.si\/en\/author\/rodrigoctgct\/","title":"Boosting Immunity After Transplantation: The Future of Automated T-Cell Therapy - CTGCT","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"nysomcoD1x\"><a href=\"https:\/\/ctgct.si\/en\/objave\/boosting-immunity-after-transplantation\/\">Boosting Immunity After Transplantation: The Future of Automated T-Cell Therapy<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/ctgct.si\/en\/objave\/boosting-immunity-after-transplantation\/embed\/#?secret=nysomcoD1x\" width=\"600\" height=\"338\" title=\"&#8220;Boosting Immunity After Transplantation: The Future of Automated T-Cell Therapy&#8221; &#8212; CTGCT\" data-secret=\"nysomcoD1x\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/ctgct.si\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"For patients undergoing a life-saving organ transplant, the road to recovery is often a delicate balancing act. While the new organ offers a second chance, the drugs needed to prevent the body from rejecting it also weaken the immune system, leaving patients vulnerable to dangerous viral infections like Cytomegalovirus (CMV).In our latest CTGCT Science Talk, PhD researcher Claudia Beltran Mestres from the Berlin Center for Advanced Therapies (Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin) shared her work on how automation can help us manufacture \"living medicines\" to protect these vulnerable patients.","thumbnail_url":"https:\/\/ctgct.si\/wp-content\/uploads\/2026\/01\/Claudia-webinar.png","thumbnail_width":1989,"thumbnail_height":1133}